Normoglycemic n = 17 | Prediabetes n = 17 | T2D n = 18 | P value | |
---|---|---|---|---|
AT dysfunction markers | ||||
ATIR | 4.12 ± 2.5 | 5.96 ± 2.8 | 7.85 ± 4.6 * | 0.009 |
ATIR/adiponectin | 0.52 (0.12–0.7) | 0.74 (0.3–1.22) | 1.1 (0.55–1.9) * | 0.047 |
Adiponectin/leptin | 4.22 (1.4–13.3) | 2.8 (1.4–6.1) | 2.4 (1.31-5) | 0.564 |
Adiponectin (µg/mL) | 8.48 (5.8–26) | 8.99 (4.3–18) | 7.0 (4.5–17) | 0.808 |
Glucose and lipid metabolism markers | ||||
Insulin (µIU/mL) | 5.97 (5.3–10.8) | 9.97 (6.7–13) * | 12 (8.1–18) * | 0.027 |
HOMA-IR | 1.28 (1.1–2.2) | 2.5 (1.6–3.4) * | 3.8 (2.8–6.2) *† | < 0.001 |
HOMA-IR/Adiponectin | 0.15 (0.04–0.40) | 0.32 (0.1–0.43) | 0.70 (0.20–1.4) * | 0.029 |
C-Peptide (pg/mL) | 607 ± 259 | 663 ± 241 | 790 ± 415 | 0.391 |
Leptin (ng/mL) | 2.58 (0.8–6.1) | 4.6 (3.0-6.1) | 3.1 (0.92–4.3) | 0.265 |
FFA (mmol/L) | 0.56 ± 0.18 | 0.59 ± 0.14 | 0.61 ± 0.2 | 0.544 |
Inflammatory markers | ||||
Resistin (ng/mL) | 3.8 ± 1.4 | 3.5 ± 0.7 | 3.6 ± 1.3 | 0.822 |
PAI-1 (ng/mL) | 7.4 ± 2.6 | 7.1 ± 2.3 | 7.6 ± 2.1 | 0.809 |
hs-CRP (mg/L) | 1.41 (0.8–2.2) | 1.02 (0.7–1.6) | 1.6 (0.92-5.0) | 0.504 |